The American Journal of Translational Research has published successful results of the Phase 3 clinical trial of Coronavir (INN: favipiravir). This study aimed to evaluate the efficacy and safety of favipiravir for treatment of mild...
The first three batches, more than 11,000 packs, of the drug Deltyba are ready for shipment to Russian healthcare facilities. The medicine for treatment of drug-resistant tuberculosis, manufactured...
In his speech at the «360 degree Pharmaceutical Supply» conference, Maxim Smagin, General Director of Promomed Group said:
The domestic health care system has...
«Vision and participation are essential to address global pharmaceutical safety challenges, including the fight against the pandemic. This means that only in conditions of...
Binnopharm Group has registered an official representative office in Kazakhstan and expects to secure representation in five more CIS countries next month – Belarus,...
Binnopharm Group, one of the largest medicine manufacturers in Russia and part of Sistema Group, announces Q3 and 9M 2021 IFRS financial results.
Q3 and...